These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 20926952

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intranasal etripamil for rapid treatment of paroxysmal supraventricular tachycardia.
    Calvert P, Gupta D.
    Future Cardiol; 2024; 20(3):163-170. PubMed ID: 38717391
    [Abstract] [Full Text] [Related]

  • 30. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias.
    Sellers TD, Kirchhoffer JB, Modesto TA.
    Prog Clin Biol Res; 1987; 230():283-99. PubMed ID: 3295883
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Adenosine-induced worsening of supraventricular tachycardia.
    Kunnumpuram GK, Patel A.
    BMJ Case Rep; 2012 Dec 10; 2012():. PubMed ID: 23230260
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
    [Abstract] [Full Text] [Related]

  • 36. The paradoxical adverse effect of verapamil for treating clinical paroxysmal supraventricular tachycardia.
    Saikawa T, Inoue K, Ohmura I, Ito S, Yonemochi H, Nakagawa M, Ito M, Ohashi K, Ebihara A.
    Jpn Heart J; 1987 Jan 01; 28(1):107-13. PubMed ID: 3599396
    [Abstract] [Full Text] [Related]

  • 37. Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia.
    Vranic II, Matic M, Perunicic J, Simic T, Soskic L, Milic N.
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jun 01; 74(6):365-71. PubMed ID: 16682179
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A prognostic index for the successful use of adenosine in patients with paroxysmal supraventricular tachycardia in emergency settings: a retrospective study.
    Xanthos T, Ekmektzoglou KA, Vlachos IS, Dimitroulis D, Tsitsilonis S, Karatzas T, Perrea DN.
    Am J Emerg Med; 2008 Mar 01; 26(3):304-9. PubMed ID: 18358941
    [Abstract] [Full Text] [Related]

  • 40. Adenosine in the management of supraventricular tachycardia in children.
    Sherwood MC, Lau KC, Sholler GF.
    J Paediatr Child Health; 1998 Feb 01; 34(1):53-6. PubMed ID: 9568942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.